KAIST Gives Antibodies “Eyes” to Detect Cancer, Targeting Cancer Mutations Inside Cells (IMAGE)
Caption
Figure 1. Schematic overview of the discovery pipeline and therapeutic activity of KRAS G12D-targeting TCR-like antibodies, integrating AI-based protein design with cell-based screening
Credit
KAIST
Usage Restrictions
No
License
Licensed content